NeuroSense Therapeutics Ltd. (NRSNW) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $8.0K | +166.7% |
| 2024 | $3.0K | -89.7% |
| 2023 | $29.0K | -58.6% |
| 2022 | $70.0K | +311.8% |
| 2021 | $17.0K | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $8.0K | +166.7% |
| 2024 | $3.0K | -89.7% |
| 2023 | $29.0K | -58.6% |
| 2022 | $70.0K | +311.8% |
| 2021 | $17.0K | — |